Offering Overview
$15M
Offering Amount (reported)
$8.5M
Sold (reported)
$6.5M
Unsold (reported)
Sold of offering amount, as of this filing56.7% sold
Federal Exemptions
506(b)
Security Types
Equity
Use of Proceeds
Research and Development$10,000,000
Clinical Trials$5,000,000
Key Personnel
Sarah Johnson
DirectorCEOPromoter
Boston, MA
Company Information
Legal Status
Limited Liability Company
Jurisdiction
Delaware
Year of Incorporation
2019
Address
456 Medical Center Blvd
Boston, MA 02115
Industry
Manufacturing
Pharmaceutical and Medicine Manufacturing
Code: 3254
Investor Information
Total Investors12
Non-Accredited2
Min Investment$100,000
Filing Details
Filing Date
November 10, 2023
First Sale Date
October 15, 2023
File Number
021-654321
Accession Number
0007654321-23-000456